Skip to main content
. Author manuscript; available in PMC: 2016 Sep 9.
Published in final edited form as: Mol Genet Metab. 2016 Apr 25;118(2):111–122. doi: 10.1016/j.ymgme.2016.04.005

Table 1.

Demographics of patients with MPS IVA in this study.

Category All MPS IVA Attenuated Severe
N 82 17 63
Gender: male: female 39:43 7: 10 31:32
Age (years) 22.40 ± 13.13 25.28 ± 13.08 21.67 ± 13.32
* Height (%) <10% 11.25 0.00 14.29
<25% 21.25 0.00 26.98
<50% 28.75 0.00 36.51
<75% 17.50 0.00 22.22
<90% 16.25 76.47 0.00
above 90% 5.00 23.53 0.00
Weight (%)* <10% 17.72 0.00 22.58
<25% 21.52 0.00 27.42
<50% 25.32 5.88 30.65
<75% 18.99 35.29 14.52
<90% 12.66 41.18 4.84
above 90% 3.80 17.65 0.00
** Operations (%) Spine 49.33 37.50 52.54
Hip 20.00 37.50 15.25
Leg (knee, femur, tibia, ankle) 52.00 37.50 55.93
Hand 4.00 6.25 3.39
Trachea 5.33 0.00 6.78
Inguinal and umbilical Hernia 6.67 0.00 8.47
Adeno and tonsillectomy 18.67 12.50 20.34
C-section 4.00 12.50 1.69

NA: not applicable.

*

Montaño et al [33] and Tomatsu et al. [34] n = 80, 2 patients did not provide phenotype.

**

n = 75, 7 patients did not provide surgical record.